Cite

HARVARD Citation

    Meißner, A. et al. (2022). Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases. Neuro-oncology. 24 (8), pp. 1331-1340. [Online]. 
  
Back to record